A) | Education | ||
B) | Open communication | ||
C) | Withholding pain medications | ||
D) | Both A and B |
Education and open communication are the keys to overcoming these barriers. Every member of the healthcare team should reinforce accurate information about pain management with patients and families. The clinician should initiate conversations about pain management, especially regarding the use of opioids, as few patients will raise the issue themselves or even express their concerns unless they are specifically asked [12]. It is important to acknowledge patients' fears individually and provide information to help them differentiate fact from fiction. For example, when discussing opioids with a patient who fears addiction, the clinician should explain that the risk of addiction is low [1]. It is also helpful to note the difference between addiction and physical dependence.
A) | Explain that pain and severity of disease are not necessarily related. | ||
B) | Assure patients that the availability of pain relievers cannot be exhausted. | ||
C) | Acknowledge that side effects may occur but emphasize that they can be managed promptly and safely. | ||
D) | All of the above |
There are several other ways clinicians can allay patients' fears about pain medication:
Assure patients that the availability of pain relievers cannot be exhausted; there will always be medications if pain becomes more severe.
Acknowledge that side effects may occur but emphasize that they can be managed promptly and safely and that some side effects will abate over time.
Explain that pain and severity of disease are not necessarily related.
A) | Expression of pain and the use of pain medication is generally the same across cultures. | ||
B) | Inadequate supplies of opioids are more likely in pharmacies in primarily white neighborhoods. | ||
C) | Communication with patients regarding level of pain may be complicated by language barriers if an interpreter is not used. | ||
D) | Some racial/ethnic minority patients have been shown to be more likely to report pain because they lack fear of side effects or addiction. |
Cultural and demographic factors may also contribute to lack of effective pain management. Expression of pain and the use of pain medication differ across cultures. For example, Hispanic and Filipino patients have been shown to be reluctant to report pain because of fear of side effects or addiction [17]. Even when effective opioids have been prescribed, access may be difficult, as inadequate supplies of opioids are more likely in pharmacies in primarily nonwhite neighborhoods [18]. Communication with patients regarding level of pain is a vital aspect of caring for patients in the end of life. When there is an obvious disconnect in the communication process between the practitioner and patient due to the patient's lack of proficiency in the English language, an interpreter is required.
A) | cancer. | ||
B) | COPD. | ||
C) | diabetes. | ||
D) | heart failure. |
The prevalence of pain at the end of life has been reported to range from 8% to 96%, occurring at higher rates among people with cancer than among adults with other life-limiting diseases [19,20]. Pain can be caused by a multitude of factors and is usually multidimensional, with pain frequently being exacerbated by other physical symptoms and by psychosocial factors, such as anxiety or depression [8].
A) | Patients' self-report | ||
B) | Results of physical examination | ||
C) | Results of functional assessment | ||
D) | Results of multidimensional assessment |
Pain should be assessed routinely, and frequent assessment has become the standard of care [8]. Pain is a subjective experience, and as such, the patient's self-report of pain is the most reliable indicator. Research has shown that pain is underestimated by healthcare professionals and overestimated by family members [8,21]. Therefore, it is essential to obtain a pain history directly from the patient, when possible, as a first step toward determining the cause of the pain and selecting appropriate treatment strategies. When the patient is unable to communicate verbally, other strategies must be used to determine the characteristics of the pain, as will be discussed.
A) | overestimated by patients. | ||
B) | overestimated by healthcare professionals. | ||
C) | underestimated by healthcare professionals. | ||
D) | underestimated by patients' family members. |
Pain should be assessed routinely, and frequent assessment has become the standard of care [8]. Pain is a subjective experience, and as such, the patient's self-report of pain is the most reliable indicator. Research has shown that pain is underestimated by healthcare professionals and overestimated by family members [8,21]. Therefore, it is essential to obtain a pain history directly from the patient, when possible, as a first step toward determining the cause of the pain and selecting appropriate treatment strategies. When the patient is unable to communicate verbally, other strategies must be used to determine the characteristics of the pain, as will be discussed.
A) | tissue lesions. | ||
B) | underlying tissue injury. | ||
C) | central nervous system damage. | ||
D) | All of the above |
Questions should be asked to elicit descriptions of the pain characteristics, including its location, distribution, quality, temporal aspect, and intensity. In addition, the patient should be asked about aggravating or alleviating factors. Pain is often felt in more than one area, and physicians should attempt to discern if the pain is focal, multifocal, or generalized. Focal or multifocal pain usually indicates an underlying tissue injury or lesion, whereas generalized pain could be associated with damage to the central nervous system. Pain can also be referred, usually an indicator of visceral pain.
A) | acute pain that develops over several days with increasing intensity. | ||
B) | transitory exacerbations of severe pain over a baseline of moderate pain. | ||
C) | pain that occurs during defined periods of time, on a regular or irregular basis. | ||
D) | pain that persists for at least three months beyond the usual course of an acute illness or injury. |
Temporal aspects of pain refer to its onset: acute, chronic, or "breakthrough." A recent onset characterizes acute pain, and there are accompanying signs of generalized hyperactivity of the sympathetic nervous system (diaphoresis and increased blood pressure and heart rate). Acute pain usually has an identifiable, precipitating cause, and appropriate treatment with analgesic agents will relieve the pain. When acute pain develops over several days with increasing intensity, it is said to be subacute. Episodic, or intermittent, pain occurs during defined periods of time, on a regular or irregular basis. Chronic pain is defined as pain that persists for at least three months beyond the usual course of an acute illness or injury. Such pain is not accompanied by overt pain behaviors (grimacing, moaning) or evidence of sympathetic hyperactivity.
A) | with only nonopioids for steps 1 and 2. | ||
B) | in a stepwise progression from step 1 to step 3. | ||
C) | in a manner according to the severity of the pain. | ||
D) | with opioids given around the clock and nonopioids given on an as-needed basis. |
The WHO analgesic ladder, introduced in 1986 and disseminated worldwide, remains recognized as a useful educational tool but not as a strict protocol for the treatment of pain. It is intended to be used only as a general guide to pain management [31]. The three-step analgesic ladder designates the type of analgesic agent based on the severity of pain (Figure 1) [31]. Step 1 of the WHO ladder involves the use of nonopioid analgesics, with or without an adjuvant (co-analgesic) agent, for mild pain (pain that is rated 1 to 3 on a 10-point scale). Step 2 treatment, recommended for moderate pain (score of 4 to 6), calls for a weak opioid, which may be used in combination with a step 1 nonopioid analgesic for unrelieved pain. Step 3 treatment is reserved for severe pain (score of 7 to 10) or pain that persists after Step 2 treatment. Strong opioids are the optimum choice of drug at Step 3. At any step, nonopioids and/or adjuvant drugs may be helpful. Some consider this model to be outdated and/or simplistic, but most agree that it remains foundational. It can be modified or revised, as needed, to apply more accurately to different patient populations.
A) | 1–1.5 g per day. | ||
B) | 3–4 g per day. | ||
C) | 5–7 g per day. | ||
D) | 8– 10 g per day. |
Nonopioid analgesics, such as aspirin, acetaminophen (Tylenol), and nonsteroidal anti-inflammatory drugs (NSAIDs), are primarily used for mild pain (Step 1 of the WHO ladder) and may also be helpful as coanalgesics at Steps 2 and 3. Acetaminophen is among the safest of analgesic agents, but it has essentially no anti-inflammatory effect. Toxicity is a concern at high doses, and the maximum recommended dose is 3–4 g per day [8]. Acetaminophen should be avoided or given at lower doses in people with a history of alcohol abuse or renal or hepatic insufficiency [8].
A) | 5 to 10 minutes. | ||
B) | 30 to 60 minutes. | ||
C) | 8 to 12 hours. | ||
D) | 12 to 18 hours. |
OPIOIDS FOR THE MANAGEMENT OF PAIN IN ADULTSa
Drug | Typical Starting Doseb | Onset of Action | Duration of Action | ||
---|---|---|---|---|---|
Codeine | 15–60 mg | 30 to 60 minutes | 4 to 6 hours | ||
Hydrocodone | 2.5–10 mg | 10 to 20 minutes | 4 to 8 hours | ||
Morphine, immediate release | 15–30 mg |
| 3 to 6 hours | ||
Oxycodone, immediate release | 5–10 mg | 10 to 30 minutes | 3 to 4 hours | ||
Oxymorphone, sustained release | 10 mg | 5 to 10 minutes | 8 to 12 hours | ||
Hydromorphone | 2–4 mg | 15 to 30 minutes | 4 to 5 hours | ||
Methadone | 5–10 mg | 30 to 60 minutes | 4 to 6 hours | ||
Tapentadol | 50–100 mg | <60 minutes | 4 to 6 hours | ||
Tapentadol, extended release | 50–100 mg | — | — | ||
Fentanyl (buccal tablet) | 100–200 mcg | 5 to 15 minutes | 2 to 4 hours | ||
Fentanyl (transdermal patch) | 25 mcg/hour (worn for 3 days) | 12 to 18 hours | 48 to 72 hours | ||
Buprenorphine (transdermal patch) | 5–10 mcg/hour (worn for 7 days) | — | — | ||
|
A) | Fentanyl | ||
B) | Morphine | ||
C) | Methadone | ||
D) | Oxycodone |
Morphine is considered to be the first-line treatment for a Step 3 opioid [34]. Morphine is available in both immediate-release and sustained-release forms, and the latter form can enhance patient compliance. The sustained-release tablets should not be cut, crushed, or chewed, as this counteracts the sustained-release properties. Morphine should be avoided in patients with severe renal failure [28].
A) | Allergy | ||
B) | Nausea | ||
C) | Sedation | ||
D) | Constipation |
Opioids are associated with many side effects, the most notable of which is constipation, occurring in nearly 100% of patients. The universality of this side effect mandates that once extended treatment with an opioid begins, prophylactic treatment with laxatives must also be initiated. Tolerance to other side effects, such as nausea and sedation, usually develops within three to seven days. Some patients may state that they are "allergic" to an opioid. It is important for the physician to explore what the patient experienced when the drug was taken in the past, as many patients misinterpret side effects as an allergy. True allergy to an opioid is rare [8]. Opioid rotation may also be done to reduce adverse events.
A) | Transportation issues | ||
B) | Patient inconvenience | ||
C) | Longer life expectancy | ||
D) | Lack of knowledge in the primary care community |
However, palliative radiotherapy has become a controversial issue. Although the benefits of palliative radiotherapy are well documented and most hospice and oncology professionals believe that palliative radiotherapy is important, this treatment approach is offered at approximately 24% of Medicare-certified freestanding hospices, with less than 3% of hospice patients being treated [56,57,58]. As previously noted, reimbursement issues present a primary barrier to the use of palliative radiotherapy [56,57,58]. Among other barriers are short life expectancy, transportation issues, patient inconvenience, and lack of knowledge about the benefits of palliative radiotherapy in the primary care community [55,56,57,59].
A) | True | ||
B) | False |
Focused relaxation and breathing can help decrease pain by easing muscle tension. Progressive muscle relaxation, in which patients follow a sequence of tensing and relaxing muscle groups, has enabled patients to feel more in control and to experience less pain and can also help provide distraction from pain [12]. This technique should be avoided if the muscle tensing will be too painful.